Nasdaq and CME Group are reintroducing the Nasdaq CME Crypto Index (NCI) to meet demand for transparency and governance in digital asset investing. The partnership reflects a shift towards regulated investment solutions as the market evolves. The index will support index-based strategies beyond just bitcoin, enhancing investor confidence and industry participation.

The collaboration between Nasdaq and CME Group builds on a 30-year partnership in equity index derivatives, reinforcing their commitment to innovation in the crypto asset class. The Nasdaq CME Crypto Index (NCI) serves as a benchmark for a range of regulated financial products, enabling portfolio construction and risk management strategies similar to equities.

Institutional investors prioritize governance when evaluating digital asset exposure. The NCI is overseen by a joint governance committee and calculated by CF Benchmarks, ensuring alignment with market practices and regulatory standards. Transparency is key, with a detailed methodology outlining eligibility criteria, liquidity thresholds, weighting rules, and quarterly reconstitution schedules.

The NCI aims to facilitate the next phase of product innovation in regulated financial products, including ETFs and structured products. Nasdaq and CME Group anticipate growing investor and issuer adoption as demand for regulated crypto exposure increases. The index is part of an ecosystem of Nasdaq digital asset indexes licensed for products globally, supporting over $1 billion in assets.

Looking ahead, Nasdaq and CME Group project increased inclusion of crypto in portfolios, shaping the future of how digital assets are accessed and managed. The NCI is positioned to establish crypto as an asset class, offering diversified portfolio opportunities for global investors. The index aims to drive adoption and shape the future of finance in the digital asset space.

Read more at Nasdaq: Nasdaq and CME Group Deepen Partnership to Advance New Era of Crypto Investing